Mission Our mission is to help leaders in genomics and precision diagnostics make high-stakes decisions that hold up in execution—where evidence, commercialization, and real-world constraints matter.
Description Founded in 2020, The Deerborne Group is a boutique management consultancy focused on genomics and precision diagnostics—markets defined by execution risk, evidence requirements, regulatory and reimbursement constraints, and commercialization complexity.
We advise senior executives, boards, and investors—including Fortune 500 companies and leading venture capital and private equity firms—on high-stakes strategic and operational decisions across the life sciences.
Backed by deep domain expertise and firsthand operating experience, The Deerborne Group helps clients translate scientific innovation into durable enterprise value through insight-driven, decision-oriented execution.